[1]BioorganicandMedicinalChemistryLetters,2012,vol.22,p.3198-3202
[2]Patent:US2006/84650,2006,A1.Locationinpatent:Page/Pagecolumn89
[3]Patent:US2010/113441,2010,A1.Locationinpatent:Page/Pagecolumn36
1005-38-5
89202-89-1 | 1,4-Dimethyl-1h-pyrazole-3-carboxylic acid | AA00890J | MFCD19228348
886503-52-2 | 4-Methoxy-2-(trifluoromethoxy)benzaldehyde | AA008A1T | MFCD06660317
885654-56-8 | 4-(Morpholinomethyl)piperidin-4-ol | AA008BDZ | MFCD06808777
884497-66-9 | 2-((2-((1-Bromonaphthalen-2-yl)oxy)ethyl)amino)ethanol | AA008CK2 | MFCD03710030
870244-35-2 | 4-Bromo-1h-pyrazolo[3,4-c]pyridin-3-amine | AA008DSM | MFCD13177853
872196-57-1 | 3-(2-Oxo-2-(piperidin-1-yl)ethoxy)benzoic acid | AA008EUV | MFCD05039657
861084-04-0 | 5-Bromo-4-methoxy-2-methylaniline | AA008FFT | MFCD17392823
859063-65-3 | Methyl 3-chloro-5-methylpyrazine-2-carboxylate | AA008G3V | MFCD10697746
850568-67-1 | 4-(2-Cyanopropan-2-yl)phenylboronic acid | AA008GQG | MFCD06659832
84956-71-8 | 2-(tert-Butyl)-4,5-dichloro-3(2h)-pyridazinone | AA008HKW | MFCD00277876